Skip to content
CrossCare

CrossCare

Het project CrossCare 2.0 stimuleert, ondersteunt en versnelt innovaties in de zorg. RheumaFinder maakt gebruik van dit programma om de implementatie van AI-gestuurde beeldanalyse…

Discover How AI is Transforming Healthcare: Insights from EOS Magazine

Discover How AI is Transforming Healthcare: Insights from EOS Magazine

We are pleased to share insights from our co-founder, Prof. Lennart Jans, recently featured in EOS magazine. The article delves…

RheumaFinder Gears Up for a Busy Spring Conference Season

RheumaFinder Gears Up for a Busy Spring Conference Season

We are excited to announce our upcoming conference engagements for the spring season, where RheumaFinder will be actively participating and…

RheumaFinder Hosts Successful Investor Event: Opening Doors for Early Detection of Rheumatic Diseases

RheumaFinder Hosts Successful Investor Event: Opening Doors for Early Detection of Rheumatic Diseases

At RheumaFinder, we are constantly seeking innovative solutions to improve the detection and treatment of rheumatic diseases. Recently, we posed…

RheumaFinder Celebrates an Important Milestone: Thomas Van Den Berghe Completes PhD

RheumaFinder Celebrates an Important Milestone: Thomas Van Den Berghe Completes PhD

RheumaFinder is thrilled to announce a significant achievement for our co-founder, Thomas Van Den Berghe, who successfully defended his PhD…

Science for health 2024

Science for health 2024

Very happy to be invited yesterday at MEDVIA’s and BioWin’s sold-out (!) #sfh2024 congress on AI, Data & Digitalisation and…

How to get a medtech startup on the rails.

How to get a medtech startup on the rails.

Great article featering RheumaFinder and our CEO Nicolaas Fosselle: https://lnkd.in/egtYqcWv on how to get a medtech startup on the rails…

The role of artificial intelligence in radiology

The role of artificial intelligence in radiology

Excellent and insightful article of our CSO Lennart Jans in Artsenkrant discussing the relevant purpose, added value and future of…

RheumaFinder Announces Investment by Novalis Biotech

RheumaFinder Announces Investment by Novalis Biotech

Februari 2024 – RheumaFinder is excited to announce an investment from Belgium’s Novalis Biotech Acceleration Fund. This investment, executed as…

New offices at the Watt Factory in Ghent

New offices at the Watt Factory in Ghent

New offices at the Watt Factory in Ghent The RheumaFinder team has moved to new offices at the Watt Factory…

RheumaFinder’s study on validating the diagnostic accuracy of AI detecting hallmark lesions gets published in European Radiology

RheumaFinder’s study on validating the diagnostic accuracy of AI detecting hallmark lesions gets published in European Radiology

Dr. Thomas Van Den Berghe’s recent study called “Neural network algorithm for detection of erosions and ankylosis on CT of…

Fund for Scientific Research in Rheumatology (FWRO/FRSR)

Fund for Scientific Research in Rheumatology (FWRO/FRSR)

Fund for Scientific Research in Rheumatology (FWRO/FRSR) Prof. Dr. Lennart Jans of RheumaFinder has been named as a recipient from…

Back To Top